JPMorgan raised the firm’s price target on Waters (WAT) to $325 from $300 and keeps a Neutral rating on the shares as part of a Q3 preview for the life science tools group. The firm sees tools companies taking a more conservative stance on 2026 pending more evidence of order improvement. JPMorgan lowered 2026 numbers for several tools companies into the quarter.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAT: